Fresenius SE Other Operating Income or Expenses 2016-2023 | FSNUY
Fresenius SE annual/quarterly other operating income or expenses history and growth rate from 2016 to 2023. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Fresenius SE other operating income or expenses for the quarter ending September 30, 2023 were $M, a NAN% increase year-over-year.
- Fresenius SE other operating income or expenses for the twelve months ending September 30, 2023 were $0M, a NAN% increase year-over-year.
- Fresenius SE annual other operating income or expenses for 2022 were $0.218B, a 75.56% increase from 2021.
- Fresenius SE annual other operating income or expenses for 2021 were $0.124B, a 56.5% decline from 2020.
- Fresenius SE annual other operating income or expenses for 2020 were $0.286B, a 23.66% decline from 2019.
Fresenius SE Annual Other Operating Income or Expenses
(Millions of US $) |
| 2022 |
$218 |
| 2021 |
$124 |
| 2020 |
$286 |
| 2019 |
$374 |
| 2018 |
$1,137 |
| 2017 |
$237 |
| 2016 |
$ |
| 2015 |
$ |
Fresenius SE Quarterly Other Operating Income or Expenses
(Millions of US $) |
| 2023-09-30 |
|
| 2023-06-30 |
|
| 2023-03-31 |
|
| 2022-12-31 |
|
| 2022-09-30 |
|
| 2022-06-30 |
|
| 2022-03-31 |
|
| 2021-12-31 |
|
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
|
| 2020-12-31 |
$250 |
| 2020-09-30 |
$4 |
| 2020-06-30 |
$6 |
| 2020-03-31 |
$26 |
| 2019-12-31 |
$358 |
| 2019-09-30 |
$3 |
| 2019-06-30 |
$12 |
| 2019-03-31 |
|
| 2018-12-31 |
$132 |
| 2018-09-30 |
$12 |
| 2018-06-30 |
$993 |
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$21.379B |
$24.011B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
